Amanote Research
Register
Sign In
Effectiveness of Supplementing Recombinant Luteinizing Hormone (R-Lh) on the Cumulative Live Birth Rate (CLB) for Poor Ovarian Responders (POR) : A Large Controlled Study
Fertility and Sterility
- Netherlands
doi 10.1016/j.fertnstert.2018.07.934
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gynecology
Reproductive Medicine
Obstetrics
Date
September 1, 2018
Authors
P. Arvis
P. Lehert
N. Massin
Publisher
Elsevier BV
Related search
Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders During in Vitro Fertilization and Embryo Transfer: A Large Retrospective Study
PLoS ONE
Multidisciplinary
Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in Vitro Fertilization Treatment: A Randomized Controlled Trial
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
When Is Recombinant Luteinizing Hormone Supplementation Beneficial During Ovarian Stimulation?
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
The Effect of Estrogen on Episodic Secretory Patterns of Luteinizing Hormone-Releasing Hormone (LHRH) and Luteinizing Hormone (LH) in Hypergonadotropic Hypogonadism
Folia Endocrinologica Japonica
GnRH Triggering May Improve Euploidy and Live Birth Rate in Hyper-Responders
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
Ovarian Stimulation Modalities in Poor Responders
Turkish Journal of Medical Sciences
Medicine
Combining Urinary Luteinizing Hormone (LH) Testing With Ultrasound Monitoring for Timing Intrauterine Insemination Cycles: A Randomized Controlled Trial
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers Following Therapy With LH-RH Agonists
Clinical Cancer Research
Cancer Research
Oncology
